tiprankstipranks
Dermapharm Holding SE (DE:DMP)
XETRA:DMP
Holding DE:DMP?
Track your performance easily

Dermapharm Holding SE (DMP) Financial Statements

10 Followers

Dermapharm Holding SE Financial Overview

Dermapharm Holding SE's market cap is currently ―. The company's EPS TTM is €1.682; its P/E ratio is 22.59; and it has a dividend yield of 2.35%. Dermapharm Holding SE is scheduled to report earnings on April 9, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue€ 263.14M€ 239.48M€ 231.64M€ 272.72M€ 242.45M
Gross Profit€ 163.27M€ 152.12M€ 146.62M€ 186.54M€ 157.00M
EBIT€ 75.54M€ 32.38M€ 59.86M€ 102.92M€ 85.73M
EBITDA€ 89.36M€ 71.33M€ 72.43M€ 122.70M€ 98.36M
Net Income Common Stockholders€ 52.45M€ 14.52M€ 37.37M€ 71.65M€ 61.81M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 145.88M€ 98.66M€ 132.52M€ 172.06M€ 131.05M
Total Assets€ 1.45B€ 1.42B€ 1.46B€ 1.41B€ 1.34B
Total Debt€ 0.00€ 634.24M€ 0.00€ 580.30M€ 0.00
Net Debt€ -145.88M€ 535.58M€ -132.52M€ 408.24M€ -131.05M
Total Liabilities€ 945.88M€ 961.43M€ 924.95M€ 907.13M€ 914.54M
Stockholders Equity€ 503.86M€ 452.99M€ 534.09M€ 497.32M€ 423.20M
Cash Flow-
Free Cash Flow€ 81.93M€ 23.03M€ 28.89M€ 88.05M€ 50.63M
Operating Cash Flow€ 89.89M€ 32.82M€ 39.51M€ 106.47M€ 69.85M
Investing Cash Flow€ -7.75M€ -9.54M€ -71.06M€ -40.53M€ -39.84M
Financing Cash Flow€ -32.67M€ -69.80M€ -3.03M€ -23.56M€ -13.07M
Currency in EUR

Dermapharm Holding SE Earnings and Revenue History

Dermapharm Holding SE Debt to Assets

Dermapharm Holding SE Cash Flow

Dermapharm Holding SE Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis